Patent ID: 11903936
Assignee: MMV MEDICINES FOR MALARIA VENTURE
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 13:
14. A pharmaceutical composition according to claim 13, wherein the co-agent is selected from artemisinin or an artemisinin and its derivatives, artemether, dihydroartemisinin, chloroquine, quinine, mefloquine, amodiaquine, atovaquone/proguanil, doxycycline, lumefantrine, piperaquine, pyronaridine, halofantrine, pyrimethamine-sulfadoxine, primaquine, quinacrine, doxycycline, atovaquone, proguanil hydrochloride, piperaquine, ferroquine, tafenoquine, arterolane, Spiro[3H-indole-3,1′-[1H]pyrido[3,4-b]indol]-2(1H)-one, 5,7′-dichloro-6′-fluoro-2′,3′,4′,9′-tetrahydro-3′-methyl-, (1′ R,3'S)-,(2-(1,1-difluoroethyl)-5-methyl-N-[4-(pentafluoro-λ6- sulfanyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine), Morpholine,4-[2-(4-cis-dispiro[cyclohexane-1,3 ′-[1,2,4]trioxolane-5′,2″-tricyclo [3.3.1.13,7]decan]-4-ylphenoxy)ethyl]-, [3,3 ‘-Bipyridin]-2-amine, 5-[4-(methylsulfonyl)phenyl]-6’-(trifluoromethyl)-, Ethanone, 2-amino-1-[2-(4-fluorophenyl)-3-[(4-fluorophenyl)amino]-5,6-dihydroimidazo[1,2-a]pyrazin-7(8 H)-yl]-.